Caprius debuts as Advanced NMR's progeny

Article

MRI developers Advanced NMR and Advanced Mammography Systems have chosen the RSNA meeting to make their debut as Caprius (Hall B, #7358), the new entity that represents the merger of the two firms. Shareholders approved the merger Nov. 11 in a deal that

MRI developers Advanced NMR and Advanced Mammography Systems have chosen the RSNA meeting to make their debut as Caprius (Hall B, #7358), the new entity that represents the merger of the two firms. Shareholders approved the merger Nov. 11 in a deal that dissolves Advanced Mammography Systems and incorporates its assets into Advanced NMR, which had been a major shareholder in AMS prior to the agreement.

The merger permits Caprius to build on the strengths of both companies, according to Jack Nelson, CEO of the Wilmington, MA, vendor. Advanced NMR is cash-rich and experienced in opening breast imaging centers, he said, while AMS owns the rights to the industry's only dedicated MR mammography scanner cleared by the Food and Drug Administration, the 0.5-tesla Aurora system.

Caprius is developing joint-venture MR breast imaging collaborations with clinical sites that have the Aurora system. The Faulkner-Sagoff Centre for Breast Health Care, the first such commercial breast imaging venture, opened earlier this month in Boston. A test site has operated since April 1996 at the University of Texas in Galveston.

On the new technology front, Caprius will describe the introduction of RODEO, a fat-suppressed pulse sequence specifically developed for breast imaging by Dr. Steven Harms. Progress with its investigation MRI-guided breast biopsy system will also be covered.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.